ARBs vary in efficacy for preventing cardiovascular events in diabetes patientsNew CMAJ study suggests that telmisartan or valsartan may be the preferred angiotensin receptor blockers for preventing cardiovascular events in patients with diabetes. Positive thinkers can lower their cardiac riskEffect could be mediated through improved stress response or healthier behaviours Longer prescription aids compliance in elderly cardiac patients And attendance at followup appointments doesn’t suffer, study shows New oral anticoagulants increase GI bleeding risk Analysis included studies that compared new oral anticoagulants to standard care; all studies had to include data on bleeding events. Niacin prescriptions rise despite questionable benefit Physicians should reconsider the role of the drug in the wake of negative trials, researcher says MI prevention: We could be doing better Screening for risk factors is not optimal Cardioviva: new probiotic modestly lowers cholesterol New cholesterol-reducing probiotic marketed as a natural health product. Water protects the kidney but not the heart High intake linked with lower chronic renal disease risk New Indication for Xarelto: Pulmonary Embolism (PE) Treatment The incidence of PE in Canada has increased significantly due to the widespread availability and sensitivity of equipment used to diagnose this illness. Water protects the kidney but not the heart High intake linked with lower chronic renal disease risk First Previous 48 49 50 51 52 Next Last